MC Healthcare Evaluation
Mike Chambers is Director of MC Healthcare Evaluation, which he founded in 2016 to provide advice on generating evidence of value of health technologies for healthcare payers, and he currently provides consultancy services to a variety of pharma companies and specialist research organisations. He contributes to a range of projects within the EU Innovative Medicines Initiative (public-private partnership), where he was a founding member of the IMI GetReal project, and he is also a member of the Technology Appraisal Committee at UK NICE. From 2006 to 2015 he was at GlaxoSmithKline, where he was head of Value Demonstration and Reimbursement in Market Access. In this role he advised on emerging evidence requirements for reimbursement and local access to medicines, and developed innovative methods for communicating the value of GSK’s medicines to healthcare decision makers. Previously he was Director of Health Economics in GSK R&D, where he led the respiratory therapy area health outcomes team. From 2001 to 2006 he was at Amersham Health/GE Healthcare, where he established a health economics function for diagnostic imaging technologies. Mike has degrees in mathematical philosophy, demography and health economics and he has also worked in the UK NHS, University of London, and in HEOR consulting.